|

DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care

RECRUITINGN/ASponsored by David Blum
Actively Recruiting
PhaseN/A
SponsorDavid Blum
Started2025-06-11
Est. completion2027-06
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06615349

Summary

The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
* Estimated life expectancy \<24 months (physician's guess)/ \>3 months
* Karnofsky Index ≥ 50% / ECOG≤ 2
* Aged \>18 years
* Owns and uses a smartphone
* Give written informed consent

Exclusion Criteria:

* Patients under curative treatment
* Relevant cognitive impairment

Conditions3

CancerTerminal CancerTerminal Illness

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.